Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease

F Dhalla, S Murray, R Sadler… - Journal of clinical …, 2015 - Springer
F Dhalla, S Murray, R Sadler, B Chaigne-Delalande, T Sadaoka, E Soilleux, G Uzel, J Miller…
Journal of clinical immunology, 2015Springer
XMEN disease (X-linked immunodeficiency with Magnesium defect, Epstein-Barr virus
infection and Neoplasia) is a novel primary immune deficiency caused by mutations in
MAGT1 and characterised by chronic infection with Epstein-Barr virus (EBV), EBV-driven
lymphoma, CD4 T-cell lymphopenia, and dysgammaglobulinemia [1]. Functional studies
have demonstrated roles for magnesium as a second messenger in T-cell receptor
signalling [1], and for NKG2D expression and consequently NK-and CD8 T-cell cytotoxicity …
Abstract
XMEN disease (X-linked immunodeficiency with Magnesium defect, Epstein-Barr virus infection and Neoplasia) is a novel primary immune deficiency caused by mutations in MAGT1 and characterised by chronic infection with Epstein-Barr virus (EBV), EBV-driven lymphoma, CD4 T-cell lymphopenia, and dysgammaglobulinemia [1]. Functional studies have demonstrated roles for magnesium as a second messenger in T-cell receptor signalling [1], and for NKG2D expression and consequently NK- and CD8 T-cell cytotoxicity [2]. 7 patients have been described in the literature; the oldest died at 45 years and was diagnosed posthumously [1–3]. We present the case of a 58-year-old Caucasian gentleman with a novel mutation in MAGT1 with the aim of adding to the phenotype of this newly described disease by detailing his clinical course over more than 20 years.
Springer